Archive: June, 2010
The Kaiser Family Foundation’s June tracking poll found that 48 percent of Americans surveyed had a somewhat favorable or very favorable opinion of the health reform bill passed in March. That was an increase from the previous month when 41 percent of those surveyed said they viewed the law favorably.
Forty-one percent said they held a very unfavorable or somewhat unfavorable view of the act passed with no Republican support in congress and signed into law by President Obama. And 27 percent supported a repeal of the law, formally known as “the Patient Protection and Affordable Care Act.”
The favorable/unfavorable numbers fell within the poll’s 4 percent margin of error, meaning Americans were essentially evenly divided in its opinion of the law. The poll was conducted with phone interviews of 1,207 adults between June 17 and June 22.
In an effort to limit financial conflicts of interest between academic medicine – hospitals, universities and doctors - and industry – drug makers and medical device companies – the Association of American Medical Colleges issued a report today establishing new guidelines to limit the impact on patient care.
The 46-page report “In the interest of Patients: Recommendations for Physician Financial Relationships and Clinical Decisions Making” was written by a 20-member panel of national medical leaders chaired by P.J. Brennan, chief medical officer of the University of Pennsylvania Health System.
“We believe these recommendations will provide guidance for how to implement policies that will meet the needs of both patients and the institutions them,” Brennan said.
A major study of the GlaxoSmithKline diabetes drug Avandia "was associated with an increased risk of stroke, heart failure, and all-cause mortality and an increased risk of the composite of AMI (Acute Myocardial Infarction), stroke, heart failure, or all-cause mortality in patients 65 years or older."
The researchers led by David J. Graham of the U.S. Food and Drug Administration examined data on 227,571 Medicare beneficiaries who took Avandia - also known as rosiglitazone - or a rival type 2 diabetes drug pioglitazone sold as Actos.
Those taking Avandia were 25 percent more likely to develop heart failure, 27 percent more likely to suffer a stroke, and 14 percent more likely to die from any cause. A story on the study and upcoming hearing is available here.
The failures of a prostate cancer program at the Philadelphia VA Medical Center and similar problems at 12 other VA hospitals has raised questions about whether the Veterans Health Administration can adequately oversee the safe use of radioactive materials in its health system.
Wednesday, top radiation safety officials from the Department of Veteran’s Affairs will testify before a panel of the U.S. Nuclear Regulatory Commission in advance of the agency’s decision on how to address three apparent violations of federal radiation safety regulations.
The NRC could levy a fine against the VA for the problems or, in a more far reaching action, strip the VA of its ability to oversee radiation services at all 153 hospitals nationwide. The commission would then take on those duties or assign them to states, such as Pennsylvania and New Jersey that have that capability.
So close. Just two months before she would get her chicken pox vaccine, my 10-month-old daughter got the virus. It kind of freaked out my wife and me over the weekend as our baby developed a fever, threw up a couple times and was cranky.
Then on Sunday, chicken pox appeared and again it was scary because we didn’t realize what it was and couldn’t get answers quickly enough for my satisfaction. So it was a hot and uncomfortable weekend here in Philly. Now her sister needs to get a booster shot a little early so that she doesn’t get it too.
All of which would be just a bit of personal drama but for a study released today by Kaiser Permanente – the giant California-based insurer and hospital system that uses its huge database to do powerful studies of various issues. The Kaiser study showed that the combined measles, mumps, rubella (German measles), and varicella (chicken pox) vaccine doubles the risk of seizures associated with high fevers – so called febrile seizures – compared with the MMR vaccine and chicken pox vaccine given separately but on the same day.
My colleague, public health writer Don Sapatkin, reports the following developments from a major study released this afternoon at a medical conference in Orlando, Fla.:
Tantalizing evidence that America's epidemic of childhood obesity may be starting to subside was presented Sunday by researchers who also found that the trend could be speeded up through programs in the schools.
Several recent studies reported that rates of overweight and obese children have plateaued during this decade after rising rapidly since 1980. But this is the first major study to detect a decline – of 4 percent – and it was in a national sample dominated by low-income blacks and Hispanics, the groups at highest risk.
The California Department of Public Health declared a whooping cough epidemic after recording a quadrupling of cases that has reached 910 so far this year. The agency said local public health agencies are investigating another 600 cases of the illness that starts with a cough and runny nose for one to two weeks.
That puts California on pace for the worse whooping cough epidemic _ with potentially more cases and deaths _ in 50 years.
Five babies, all under three months of age, have died of the vaccine-preventable illness and the state agency urged that all Californians get vaccinated against the disease.
Hospitals in the Philadelphia region fared poorly in so-called hospital-acquired infections in 2009, according to a new report issued by the Pennsylvania Department of Health. Overall, 250 hospitals across the commonwealth reported that 25,914 patients contracted infection during the course of their care.
The report due out Tuesday afternoon detailed the number of infections at each of the hospitals and included a detailed examination of two common types of infections – catheter-associated urinary tract infections and central-line-associated bloodstream infections.
Of the 194 hospitals that reported urinary tract infections, 32 had rates that were significantly higher than expected based on the type patients treated. Nearly half (15) of those were in Philadelphia or its Pennsylvania suburbs. In contrast, 12 of the 44 hospitals with better than expected rates of catheter-associated urinary tract infections were based in the region.
And 13 of the 19 hospitals that had higher than expected rates of central-line associated bloodstream infections were from the Philadelphia region. Philadelphia hospitals accounted for four of the 22 hospitals that achieved better than expected results.